CC BY 4.0 · Surg J (N Y) 2021; 07(03): e241-e250
DOI: 10.1055/s-0041-1735587
Review Article

A Meta-analysis of Transanal Endoscopic Microsurgery versus Total Mesorectal Excision in the Treatment of Rectal Cancer

1   Department of Surgery, University Hospital Limerick, Limerick, Republic of Ireland
,
Muhammad Hasan Abbas
2   Department of Surgery, Russells Hall Hospital, NHS Trust, West Midlands, Dudley, United Kingdom
,
Mohamed H. Abunada
3   Department of Surgery, Hamad Medical Hospital, Doha, Qatar
,
Amjad Parvaiz
4   Faculty of Health Sciences, University of Portsmouth, Portsmouth, England
5   Department of Colorectal Surgery, Poole NHS Trust, Poole, United Kingdom
› Author Affiliations
Funding None.

Abstract

Background Transanal endoscopic microsurgery (TEMS) has been suggested as an alternative to total mesorectal excision (TME) in the treatment of early rectal cancers. The extended role of TEMS for higher stage rectal cancers after neoadjuvant therapy is also experimented. The aim of this meta-analysis was to compare the oncological outcomes and report on the evidence-based clinical supremacy of either technique.

Methods Medline, Embase, and Cochrane databases were searched for the randomized controlled trials comparing the oncological and perioperative outcomes of TEMS and a radical TME. A local recurrence and postoperative complications were analyzed as primary end points. Intraoperative blood loss, operation time, and duration of hospital stay were compared as secondary end points.

Results There was no statistical difference in the local recurrence or postoperative complications with a risk ratio of 1.898 and 0.753 and p-values of 0.296 and 0.306, respectively, for TEMS and TME. A marked statistical significance in favor of TEMS was observed for secondary end points. There was standard difference in means of −4.697, −6.940, and −5.685 with p-values of 0.001, 0.005, and 0.001 for blood loss, operation time, and hospital stay, respectively.

Conclusion TEMS procedure is a viable alternative to TME in the treatment of early rectal cancers. An extended role of TEMS after neoadjuvant therapy may also be offered to a selected group of patients. TME surgery remains the standard of care in more advanced rectal cancers.

Ethical Approval

Not applicable.




Publication History

Received: 29 December 2020

Accepted: 22 July 2021

Article published online:
14 September 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery–the clue to pelvic recurrence?. Br J Surg 1982; 69 (10) 613-616
  • 2 Buess G, Theiss R, Günther M, Hutterer F, Pichlmaier H. Endoscopic surgery in the rectum. Endoscopy 1985; 17 (01) 31-35
  • 3 Buess G, Theiss R, Hutterer F. et al. [Transanal endoscopic surgery of the rectum - testing a new method in animal experiments]. Leber Magen Darm 1983; 13 (02) 73-77
  • 4 Arezzo A, Arolfo S, Allaix ME. et al. Transanal endoscopic microsurgery for giant circumferential rectal adenomas. Colorectal Dis 2016; 18 (09) 897-902
  • 5 Buess G, Kipfmüller K, Naruhn M, Braunstein S, Junginger T. Endoscopic microsurgery of rectal tumors. Endoscopy 1987; 19 (Suppl. 01) 38-42
  • 6 de Graaf EJ, Burger JW, van Ijsseldijk AL, Tetteroo GW, Dawson I, Hop WC. Transanal endoscopic microsurgery is superior to transanal excision of rectal adenomas. Colorectal Dis 2011; 13 (07) 762-767
  • 7 Clancy C, Burke JP, Albert MR, O'Connell PR, Winter DC. Transanal endoscopic microsurgery versus standard transanal excision for the removal of rectal neoplasms: a systematic review and meta-analysis. Dis Colon Rectum 2015; 58 (02) 254-261
  • 8 Baatrup G, Svensen R, Ellensen VS. Benign rectal strictures managed with transanal resection–a novel application for transanal endoscopic microsurgery. Colorectal Dis 2010; 12 (02) 144-146
  • 9 D'Ambrosio G, Paganini AM, Guerrieri M. et al. Minimally invasive treatment of rectovaginal fistula. Surg Endosc 2012; 26 (02) 546-550
  • 10 Bloemendaal AL, De Schepper M, Mishra A. et al. Trans-anal endoscopic microsurgery for internal rectal prolapse. Tech Coloproctol 2016; 20 (02) 129-133
  • 11 Arezzo A. To TEM or not to TEM: past, present and probable future perspectives of the transanal endoscopic microsurgery platform. Tech Coloproctol 2016; 20 (05) 271-272
  • 12 Lezoche E, Guerrieri M, Paganini AM. et al. Transanal endoscopic versus total mesorectal laparoscopic resections of T2-N0 low rectal cancers after neoadjuvant treatment: a prospective randomized trial with a 3-years minimum follow-up period. Surg Endosc 2005; 19 (06) 751-756
  • 13 Lezoche G, Baldarelli M, Guerrieri M. et al. A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 2008; 22 (02) 352-358
  • 14 Sajid MS, Farag S, Leung P, Sains P, Miles WF, Baig MK. Systematic review and meta-analysis of published trials comparing the effectiveness of transanal endoscopic microsurgery and radical resection in the management of early rectal cancer. Colorectal Dis 2014; 16 (01) 2-14
  • 15 Serra-Aracil X, Mora-Lopez L, Alcantara-Moral M, Caro-Tarrago A, Gomez-Diaz CJ, Navarro-Soto S. Transanal endoscopic surgery in rectal cancer. World J Gastroenterol 2014; 20 (33) 11538-11545
  • 16 Veereman G, Vlayen J, Robays J. et al. Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: a real standard?. Crit Rev Oncol Hematol 2017; 114: 43-52
  • 17 Chiniah M, Ganganah O, Cheng Y, Sah SK. Transanal endoscopic microsurgery is an oncologically safe alternative to total mesorectal excision for stage I rectal cancer: results of a meta-analysis of randomized controlled trials. Int J Colorectal Dis 2016; 31 (08) 1501-1504
  • 18 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535
  • 19 Jadad AR, Moore RA, Carroll D. et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996; 17 (01) 1-12
  • 20 Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13
  • 21 Winde G, Nottberg H, Keller R, Schmid KW, Bünte H. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum 1996; 39 (09) 969-976
  • 22 Lezoche E, Baldarelli M, Lezoche G, Paganini AM, Gesuita R, Guerrieri M. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg 2012; 99 (09) 1211-1218
  • 23 Chen YY, Liu ZH, Zhu K, Shi PD, Yin L. Transanal endoscopic microsurgery versus laparoscopic lower anterior resection for the treatment of T1-2 rectal cancers. Hepatogastroenterology 2013; 60 (124) 727-732
  • 24 Burghardt J, Buess G. Transanal endoscopic microsurgery (TEM): a new technique and development during a time period of 20 years. Surg Technol Int 2005; 14: 131-137
  • 25 Tytherleigh MG, Warren BF, Mortensen NJ. Management of early rectal cancer. Br J Surg 2008; 95 (04) 409-423
  • 26 Ortenzi M, Ghiselli R, Paolucci A, Guerrieri M. The feasibility of laparoscopic rectal resection in patients undergoing reoperation after transanal endoscopic microsurgery (TEM). Surg Endosc 2018; 32 (04) 2020-2025
  • 27 Park SM, Kye BH, Kim MK, Jalloun HE, Cho HM, Lee IK. Are we doing too much?: local excision before radical surgery in early rectal cancer. Int J Colorectal Dis 2018; 33 (04) 383-391
  • 28 Ondhia M, Tamvakeras P, O'Toole P. et al; Merseyside Early Rectal Cancer Network. Transanal endoscopic microsurgery for rectal lesions in a specialist regional early rectal cancer centre: the Mersey experience. Colorectal Dis 2019; 21 (10) 1164-1174
  • 29 Peltrini R, Sacco M, Luglio G, Bucci L. Local excision following chemoradiotherapy in T2-T3 rectal cancer: current status and critical appraisal. Updates Surg 2020; 72 (01) 29-37
  • 30 Amann M, Modabber A, Burghardt J. et al. Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 low-risk carcinomas. World J Surg Oncol 2012; 10: 255
  • 31 Chang AJ, Nahas CS, Araujo SE. et al. Early rectal cancer: local excision or radical surgery?. J Surg Educ 2008; 65 (01) 67-72
  • 32 De Graaf EJ, Doornebosch PG, Tollenaar RA. et al. Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur J Surg Oncol 2009; 35 (12) 1280-1285
  • 33 Ganai S, Kanumuri P, Rao RS, Alexander AI. Local recurrence after transanal endoscopic microsurgery for rectal polyps and early cancers. Ann Surg Oncol 2006; 13 (04) 547-556
  • 34 Whitehouse PA, Armitage JN, Tilney HS, Simson JN. Transanal endoscopic microsurgery: local recurrence rate following resection of rectal cancer. Colorectal Dis 2008; 10 (02) 187-193
  • 35 McCloud JM, Waymont N, Pahwa N. et al. Factors predicting early recurrence after transanal endoscopic microsurgery excision for rectal adenoma. Colorectal Dis 2006; 8 (07) 581-585
  • 36 Doornebosch PG, Ferenschild FT, de Wilt JH, Dawson I, Tetteroo GW, de Graaf EJ. Treatment of recurrence after transanal endoscopic microsurgery (TEM) for T1 rectal cancer. Dis Colon Rectum 2010; 53 (09) 1234-1239
  • 37 Stipa F, Giaccaglia V, Burza A. Management and outcome of local recurrence following transanal endoscopic microsurgery for rectal cancer. Dis Colon Rectum 2012; 55 (03) 262-269
  • 38 Dulskas A, Atkociunas A, Kilius A, Petrulis K, Samalavicius NE. Is previous transanal endoscopic microsurgery for early rectal cancer a risk factor of worse outcome following salvage surgery a case-matched analysis. Visc Med 2019; 35 (03) 151-155
  • 39 Levic K, Bulut O, Hesselfeldt P, Bülow S. The outcome of rectal cancer after early salvage TME following TEM compared with primary TME: a case-matched study. Tech Coloproctol 2013; 17 (04) 397-403
  • 40 Weiser MR, Landmann RG, Wong WD. et al. Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 2005; 48 (06) 1169-1175
  • 41 Friel CM, Cromwell JW, Marra C, Madoff RD, Rothenberger DA, Garcia-Aguílar J. Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum 2002; 45 (07) 875-879
  • 42 Issa N, Murninkas A, Schmilovitz-Weiss H, Agbarya A, Powsner E. Transanal endoscopic microsurgery after neoadjuvant chemoradiotherapy for rectal cancer. J Laparoendosc Adv Surg Tech A 2015; 25 (08) 617-624
  • 43 Rizzo G, Zaccone G, Magnocavallo M. et al. Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer. Eur J Surg Oncol 2017; 43 (08) 1488-1493
  • 44 Creavin B, Ryan E, Martin ST. et al. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. Br J Cancer 2017; 116 (02) 169-174
  • 45 Guerrieri M, Gesuita R, Ghiselli R, Lezoche G, Budassi A, Baldarelli M. Treatment of rectal cancer by transanal endoscopic microsurgery: experience with 425 patients. World J Gastroenterol 2014; 20 (28) 9556-9563
  • 46 Stijns RCH, de Graaf EJR, Punt CJA. et al; CARTS Study Group. Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study. JAMA Surg 2019; 154 (01) 47-54
  • 47 van Heinsbergen M, Leijtens JW, Slooter GD, Janssen-Heijnen ML, Konsten JL. Quality of life and bowel dysfunction after transanal endoscopic microsurgery for rectal cancer: one third of patients experience major low anterior resection syndrome. Dig Surg 2020; 37 (01) 39-46
  • 48 Lezoche E, Paganini AM, Fabiani B. et al. Quality-of-life impairment after endoluminal locoregional resection and laparoscopic total mesorectal excision. Surg Endosc 2014; 28 (01) 227-234
  • 49 Marques CF, Nahas CS, Ribeiro Jr U. et al. Postoperative complications in the treatment of rectal neoplasia by transanal endoscopic microsurgery: a prospective study of risk factors and time course. Int J Colorectal Dis 2016; 31 (04) 833-841
  • 50 Beets GL, Figueiredo NF, Beets-Tan RG. Management of rectal cancer without radical resection. Annu Rev Med 2017; 68: 169-182